CAS 216227-54-2

N-[4-[2-[4-[3-Ethoxy-1(E)-propenyl]phenyl]-4-[4-(isopropylamino)phenyl]-1H-imidazol-5-yl]phenyl]-N-isopropylamine

Description:

N-[4-[2-[4-[3-Ethoxy-1(E)-propenyl]phenyl]-4-[4-(isopropylamino)phenyl]-1H-imidazol-5-yl]phenyl]-N-isopropylamine, with CAS number 216227-54-2, is a complex organic compound characterized by its multi-functional structure, which includes an imidazole ring and various aromatic groups. This compound features an ethoxy group and a propenyl moiety, contributing to its potential reactivity and biological activity. The presence of isopropylamine suggests possible interactions with biological systems, making it of interest in medicinal chemistry. Its structural complexity may influence its solubility, stability, and interaction with biological targets. The compound's synthesis and characterization would typically involve standard organic chemistry techniques, including chromatography and spectroscopy for purity and structural confirmation. Given its intricate design, it may exhibit specific pharmacological properties, potentially acting as a ligand or inhibitor in various biochemical pathways. Further studies would be necessary to elucidate its full range of characteristics, including its efficacy, safety, and potential applications in therapeutic contexts.

Formula: C₃₂H₃₈N₄O

InChI: InChI=1/C32H38N4O/c1-6-37-21-7-8-24-9-11-27(12-10-24)32-35-30(25-13-17-28(18-14-25)33-22(2)3)31(36-32)26-15-19-29(20-16-26)34-23(4)5/h7-20,22-23,33-34H,6,21H2,1-5H3,(H,35,36)/b8-7+

Synonyms:

• OC-144-093
• 4,4'-(2-{4-[(1E)-3-ethoxyprop-1-en-1-yl]phenyl}-1H-imidazole-4,5-diyl)bis[N-(1-methylethyl)aniline]
• OC144-093
• ONT-093
• 2-[4-[3-Ethoxy-1(E)-propenyl]phenyl]-4,5-bis[4-(isopropylamino)phenyl]-1H-imidazole

ONT-093

CAS: 216227-54-2

ONT-093

Purity: ≥98%

Molecular weight: 494.67g/mol

Ref: 54-BUP20052

4-[2-[4-[(E)-3-Ethoxyprop-1-enyl]phenyl]-4-[4-(propan-2-ylamino)phenyl]-1H-imidazol-5-yl]-N-propan-2-ylaniline

Controlled Product

CAS: 216227-54-2

4-[2-[4-[(E)-3-Ethoxyprop-1-enyl]phenyl]-4-[4-(propan-2-ylamino)phenyl]-1H-imidazol-5-yl]-N-propan-2-ylaniline (BMS182874) is an inhibitor of the ATPase pump that is responsible for maintaining the integrity of the cell membrane, which is a key component in cancer therapy. The drug has been shown to inhibit tumor metastasis and tumor growth in animal models. BMS182874 also inhibits the insulin receptor signaling pathway, leading to insulin resistance and diabetes mellitus type 2. This drug has been shown to inhibit chaperone function, which may be due to its ability to bind to beta barrel structures, such as those found in HSP90 and HSP70 proteins. BMS182874 was originally designed as a diagnostic agent for prostate cancer and autoimmune diseases, but it has

Formula: C₃₂H₃₈N₄O

Purity: Min. 95%

Molecular weight: 494.7 g/mol

Ref: 3D-RIA22754

ONT-093

CAS: 216227-54-2

ONT-093 (OC-144-093) is an oral P-glycoprotein (P-gp) inhibitor with potential anti-cancer activity, used in the study of myelodysplastic syndromes.

Formula: C₃₂H₃₈N₄O

Purity: 98.86%

Color and Shape: Solid

Molecular weight: 494.67

Ref: TM-T63338